A novel recombinant vaccinia virus expressing the human norepinephrine transporter retains oncolytic potential and facilitates deep-tissue imaging

Molecular Medicine

Volumn 15, Issue 5-6, 2009, Pages 144-151

  Chen, Nanhai ^a   Zhang, Qian ^a   Yu, Yong A ^a   Stritzker, Jochen ^a,b   Brader, Peter ^c,d   Schirbel, Andreas ^e   Samnick, Samuel ^e   Serganova, Inna ^c   Blasberg, Ronald ^c   Fong, Yuman ^c   Szalay, Aladar A ^a,b  

^a GENELUX CORPORATION   (United States)

^b UNIVERSITY OF WÜRZBURG   (Germany)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^d MEDICAL UNIVERSITY OF GRAZ   (Austria)

^e UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 124; (3 IODOBENZYL)GUANIDINE I 131; GLV 1H68; GLV 1H99; NORADRENALIN TRANSPORTER; ONCOLYTIC VIRUS; RADIOISOTOPE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL STRAIN COS7; CONTROLLED STUDY; CYTOLYSIS; DRUG EFFICACY; EXPERIMENTAL NEOPLASM; FEMALE; GENE LOCUS; HUMAN; HUMAN CELL; MALE; MOLECULAR IMAGING; MOUSE; NONHUMAN; ONCOLYTIC VIROTHERAPY; PANCREAS CARCINOMA; PLEURA MESOTHELIOMA; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; RADIOACTIVITY; VACCINIA VIRUS; VIRUS RECOMBINANT; VIRUS REPLICATION;

ANIMALS; BLOTTING, WESTERN; CELL LINE; CELL LINE, TUMOR; CERCOPITHECUS AETHIOPS; DIAGNOSTIC IMAGING; HUMANS; MICE; MICROSCOPY, FLUORESCENCE; NEOPLASM TRANSPLANTATION; NEOPLASMS; NOREPINEPHRINE PLASMA MEMBRANE TRANSPORT PROTEINS; ONCOLYTIC VIROTHERAPY; TRANSPLANTATION, HETEROLOGOUS; VACCINIA VIRUS;

EID: 66449136320     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.2119/molmed.2009.00014     Document Type: Article

References (29)

1. Vasey PA, et al. (2002) Phase I trial of intraperitoneal injection of the E1B-55-kd-gene-deleted adenovirus ONYX-015 (dl1520) given on days 1 through 5 every 3 weeks in patients with recurrent/refractory epithelial ovarian cancer. J. Clin. Oncol. 20:1562-9.
2. Adusumilli PS, et al. (2006) Real-time diagnostic imaging of tumors and metastases by use of a replication-competent herpes vector to facilitate minimally invasive oncological surgery. FASEB J. 20:726-8.
3. Sinkovics JG, Horvath JC. (2000) Newcastle disease virus (NDV): brief history of its oncolytic strains. J. Clin. Virol. 16:1-15.
4. Woo Y, et al. (2008) Myxoma virus is oncolytic for human pancreatic adenocarcinoma cells. Ann. Surg. Oncol. 15:2329-35.
5. Zhang Q, et al. (2007) Eradication of solid human breast tumors in nude mice with an intravenously injected light-emitting oncolytic vaccinia virus. Cancer Res. 67:10038-46.
6. Barber GN. (2004) Vesicular stomatitis virus as an oncolytic vector. Viral Immunol. 17:516-27.
7. Adusumilli PS, et al. (2007) Radiation-induced cellular DNA damage repair response enhances viral gene therapy efficacy in the treatment of malignant pleural mesothelioma. Ann. Surg. Oncol. 14:258-69.
8. Petrowsky H, et al. (2001) Functional interaction between fluorodeoxyuridine-induced cellular alterations and replication of a ribonucleotide re- ductase-negative herpes simplex virus. J. Virol. 75:7050-8.
9. Roizman B, Joklik W, Fields B, Moss B. (1994) The destruction of smallpox virus stocks in national repositories: a grave mistake and a bad precedent. Infect. Agents Dis. 3:215-7.
10. Shulkin BL, et al. (1986) Iodine-123-4-amino-3- iodobenzylguanidine, a new sympathoadrenal imaging agent: comparison with iodine-123 meta- iodobenzylguanidine. J. Nucl. Med. 27:1138-42.
11. Moroz MA, et al. (2007) Imaging hNET reporter gene expression with 124I-MIBG. J. Nucl. Med. 48:827-36.
12. Axelrod J, Kopin IJ. (1969) The uptake, storage, release and metabolism of noradrenaline in sympathetic nerves. Prog. Brain Res. 31:21-32.
13. Buursma AR, et al. (2005) The human norepi- nephrine transporter in combination with 11C-m- hydroxyephedrine as a reporter gene/reporter probe for PET of gene therapy. J. Nucl. Med. 46:2068-75.
14. Falkner FG, Moss B. (1990) Transient dominant selection of recombinant vaccinia viruses. J. Virol. 64:3108-11.
15. Samnick S, Kirsch CM. (1999) A simple and rapid routine preparation of no-carrier added meta-I-123- and I-131-iodobenzylguanidine (I-123-MIBG and I-131-MIBG) for clinical nuclear medicine applications [in German]. Nuklearmedizin 38:292-6.
16. Brader P, et al. (2008) Escherichia coli Nissle 1917 facilitates tumor detection by positron emission tomography and optical imaging. Clin. Cancer Res. 14:2295-302.
17. Melikian HE, et al. (1994) Human norepineph- rine transporter: biosynthetic studies using a site-directed polyclonal antibody. J. Biol. Chem. 269:12290-7.
18. Yu YA, et al. (2009) Regression of human pancreatic tumor xenografts in mice after a single systemic injection of recombinant vaccinia virus GLV-1h68. Mol. Cancer Ther. 8:141-51.
19. Anton M, et al. (2004) Use of the norepinephrine transporter as a reporter gene for non-invasive imaging of genetically modified cells. J. Gene Med. 6:119-26.
20. Thorne SH, Hwang TH, Kirn DH. (2005) Vaccinia virus and oncolytic virotherapy of cancer. Curr. Opin. Mol. Ther. 7:359-65.
21. Pantuck AJ, et al. (2004) Phase I trial of antigen- specific gene therapy using a recombinant vaccinia virus encoding MUC-1 and IL-2 in MUC-1- positive patients with advanced prostate cancer. J. Immunother. 27:240-53.
22. Marshall JL, et al. (2005) Phase I study of sequential vaccinations with fowlpox-CEA(6D)-TRICOM alone and sequentially with vaccinia-CEA(6D)- TRICOM, with and without granulocyte- macrophage colony-stimulating factor, in patients with carcinoembryonic antigen-expressing carcinomas. J. Clin. Oncol. 23:720-31.
23. Lin SF, et al. (2007) Treatment of anaplastic thyroid carcinoma in vitro with a mutant vaccinia virus. Surgery 142:976-83.
24. Chalikonda S, et al. (2008) Oncolytic virotherapy for ovarian carcinomatosis using a replication- selective vaccinia virus armed with a yeast cytosine deaminase gene. Cancer Gene Ther. 15:115-25.
25. Chang E, et al. (2005) Targeting vaccinia to solid tumors with local hyperthermia. Hum. Gene Ther. 16:435-44.
26. Kelly KJ, et al. (2008) Novel oncolytic agent GLV-1h68 is effective against malignant pleural mesothelioma. Hum. Gene Ther. 19:774-82.
27. Baldick CJ Jr, Moss B. (1993) Characterization and temporal regulation of mRNAs encoded by vaccinia virus intermediate-stage genes. J. Virol. 67:3515-27.
28. Chakrabarti S, Sisler JR, Moss B. (1997) Compact, synthetic, vaccinia virus early/late promoter for protein expression. Biotechniques 23:1094-7.
29. Ferrone CR, et al. (2008) Pancreatic adenocarci- noma: the actual 5-year survivors. J. Gastrointest. Surg. 12:701-6.